Insights with Goldman Sachs Part 1: Future predictions
Biopharma has been on a roller coaster for the past few years. Now, a more predictable global ecosystem, incredible innovation in science and technology, and a booming investment environment are opening-up exciting opportunities for large pharma and biotechs alike. Tune in for more future predictions from our panel discussion including Jerry Lee, Partner of Global Healthcare Investment Banking Group at Goldman Sachs, and Lyla Bibi, Managing Director and Head of Americas Healthcare Equity Capital Markets at Goldman Sachs.
Disclaimer: The views and opinions that the panelists express are their own and are for informational purposes only. They do not constitute a recommendation by Goldman Sachs Asset Management for you to take any action.